home / stock / awh / awh news


AWH News and Press, Aspira Women's Health Inc. From 03/25/21

Stock Information

Company Name: Aspira Women's Health Inc.
Stock Symbol: AWH
Market: NASDAQ
Website: aspirawh.com

Menu

AWH AWH Quote AWH Short AWH News AWH Articles AWH Message Board
Get AWH Alerts

News, Short Squeeze, Breakout and More Instantly...

AWH - Aspira Women's Health Reports Fourth Quarter and Full Year 2020 Financial Results

AUSTIN, Texas, March 25, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the fourth quarter and year ended Decembe...

AWH - Aspira Women's Health, Inc. Announces an Agreement for the Development and Commercialization of an Early-Detection Test for Identification of Ovarian Cancer

AUSTIN, Texas, March 25, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it has entered into an agreement with Dana-Farber Cancer Institute (DFCI), Brigham and Women’s Hospital, and Medica...

AWH - Aspira Women's Health Inc. to Report Fourth Quarter and Full Year 2020 Financial Results

AUSTIN, Texas, March 18, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will report financial results for the fourth quarter and full year ended December 31 st , 2020, on Thursday, M...

AWH - Aspira Women's Health Inc. Announcement New York State Medicaid Now Considers OVA1® Medically Necessary as of April 1, 2021

Second Largest Medicaid population in the U.S. AUSTIN, Texas, March 15, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), today announced its wholly owned subsidiary, Aspira Labs, is now credentialed with New York State’s Medicaid program for an ...

AWH - Aspira Women's Health Inc. Appoints Nicole Sandford to its Board of Directors

AUSTIN, Texas, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced the appointment of Ms. Nicole Sandford to its Board of Directors. “I am very pleased to warmly welcome Nicole t...

AWH - Aspira Women's Health Recognizes the Importance of Bridging the Gap in Ovarian Cancer Risk Assessment Disparities During Black History Month

AUSTIN, Texas, Feb. 17, 2021 (GLOBE NEWSWIRE) -- February is recognized as Black History Month, a time to honor the contributions of Black Americans to culture and society while elevating the voices of those fighting for equity and justice. This month, Aspira Women’s Health Inc. (Nas...

AWH - Aspira Women's Health, Inc. to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

AUSTIN, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced management will participate and present in the 2021 BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools...

AWH - Aspira Women's Health, Inc. to add NCCN Management Recommendations to its Proprietary Aspira GenetiX(TM) Clinical Report

AUSTIN, Texas, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced they will incorporate management recommendations from NCCN Guidelines ® into our Aspira GenetiX Clinical reports. ...

AWH - Anavex Life Sciences, Annovis Bio leads healthcare gainers; Tyme Technologies, Isoray among major losers

Gainers: Anavex Life Sciences (AVXL) +94%, Annovis Bio (ANVS) +50%, Atossa Therapeutics (ATOS) +40%, Cyclerion Therapeutics (CYCN) +40%, Cyclo Therapeutics (CYTH) +33%.Losers: Tyme Technologies (TYME) -36%, Isoray (ISR) -19%, Lannett...

AWH - Aspira Women's Health Inc. Announces Pricing of $45 Million Public Offering of Common Stock

AUSTIN, Texas, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the pricing of the previously announced underwritten public offerin...

Previous 10 Next 10